Business description
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retina diseases including all stages of age-related macular degeneration.
Management board & Supervisory board
| CEO |
| Glenn P. Sblendorio |
| Management board |
| David F. Carroll, Keith Westby, Pravin U. Dugel |
| Supervisory board |
| Adrienne L. Graves, Axel Bolte, Calvin Roberts, Glenn P. Sblendorio, Jane Pritchett Henderson, Mark S. Blumenkranz |
Company data
| Name: |
Iveric Bio Inc. |
| Address: |
Five Penn Plaza, Suite 2372,New York, NY 10001, USA |
| Phone: |
+1-212-845-8200 |
| Fax: |
- |
| E-mail: |
info@ivericbio.com
|
| Internet: |
https://ivericbio.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2016-12-16 |
